Altmetric

A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab versus investigator's choice in the treatment of patients with relapsed/refractory adult tTcell leukemia-lymphoma: overall response rate, progression-free survival, and overall survival

Title: A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab versus investigator's choice in the treatment of patients with relapsed/refractory adult tTcell leukemia-lymphoma: overall response rate, progression-free survival, and overall survival
Authors: Phillips, A
Fields, P
Hermine, O
Ramos, JC
Beltran, BE
Pereira, J
Brites, C
Wandroo, FA
Lill, M
Feldman, TA
Casanova, L
Janakiram, M
Meniane, J-C
Sawas, A
Cook, LB
Kurman, MR
George, J
Dwyer, K
Leoni, M
Conlon, K
Taylor, GP
Gonsky, J
Horwitz, SM
Item Type: Conference Paper
Issue Date: 2-Dec-2016
Date of Acceptance: 1-Jun-2021
URI: http://hdl.handle.net/10044/1/104890
DOI: 10.1182/blood.V128.22.4159.4159
ISSN: 0006-4971
Publisher: American Society of Hematology
Start Page: 4159
End Page: 4159
Journal / Book Title: Blood
Volume: 128
Issue: 22
Copyright Statement: © 2016 by The American Society of Hematology
Conference Name: 58th ASH Annual Meeting and Exposition
Publication Status: Published
Start Date: 2016-12-03
Finish Date: 2016-12-06
Conference Place: San Diego, CA
Open Access location: https://doi.org/10.1182/blood.V128.22.4159.4159
Online Publication Date: 2021-06-15
Appears in Collections:Department of Immunology and Inflammation
Department of Infectious Diseases